Cisplatin Market - Global Outlook and Forecast 2021-2027

April 2021 | 109 pages | ID: CEE8DF405615EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cisplatin in Global, including the following market information:

Global Cisplatin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cisplatin market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cisplatin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cisplatin Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cisplatin Market Segment Percentages, By Type, 2020 (%)

• Tablets
• Injection

China Cisplatin Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cisplatin Market Segment Percentages, By Application, 2020 (%)

• Testicular Cancer
• Osteosarcoma
• Breast Cancer

Global Cisplatin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cisplatin Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cisplatin Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cisplatin Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Eli Lilly and Company
• Hospira
• Pfizer
• Bedford Pharmaceuticals
• Alvogen
• Athenex Pharmaceutical
• Gland Pharma (Fosun Pharma)
• West-Ward Pharmaceuticals
• WG Critical Care
• David Bull Laboratories
• Omega Laboratories
• Fresenius Kabi
• TEVA
• Mylan Pharmaceuticals
• Yunnan Plant Pharmaceutical
• Yunnan Biological Valley Pharmaceutical
• Dezhou de Pharmaceutical
• Jiangsu Haosen Pharmaceutical Group
• Qilu Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cisplatin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cisplatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CISPLATIN OVERALL MARKET SIZE

2.1 Global Cisplatin Market Size: 2021 VS 2027
2.2 Global Cisplatin Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cisplatin Players in Global Market
3.2 Top Global Cisplatin Companies Ranked by Revenue
3.3 Global Cisplatin Revenue by Companies
3.4 Top 3 and Top 5 Cisplatin Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cisplatin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cisplatin Players in Global Market
  3.6.1 List of Global Tier 1 Cisplatin Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cisplatin Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cisplatin Market Size Markets, 2021 & 2027
  4.1.2 Tablets
  4.1.3 Injection
4.2 By Type - Global Cisplatin Revenue & Forecasts
  4.2.1 By Type - Global Cisplatin Revenue, 2016-2021
  4.2.2 By Type - Global Cisplatin Revenue, 2022-2027
  4.2.3 By Type - Global Cisplatin Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cisplatin Market Size, 2021 & 2027
  5.1.2 Testicular Cancer
  5.1.3 Osteosarcoma
  5.1.4 Breast Cancer
5.2 By Application - Global Cisplatin Revenue & Forecasts
  5.2.1 By Application - Global Cisplatin Revenue, 2016-2021
  5.2.2 By Application - Global Cisplatin Revenue, 2022-2027
  5.2.3 By Application - Global Cisplatin Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cisplatin Market Size, 2021 & 2027
6.2 By Region - Global Cisplatin Revenue & Forecasts
  6.2.1 By Region - Global Cisplatin Revenue, 2016-2021
  6.2.2 By Region - Global Cisplatin Revenue, 2022-2027
  6.2.3 By Region - Global Cisplatin Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cisplatin Revenue, 2016-2027
  6.3.2 US Cisplatin Market Size, 2016-2027
  6.3.3 Canada Cisplatin Market Size, 2016-2027
  6.3.4 Mexico Cisplatin Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cisplatin Revenue, 2016-2027
  6.4.2 Germany Cisplatin Market Size, 2016-2027
  6.4.3 France Cisplatin Market Size, 2016-2027
  6.4.4 U.K. Cisplatin Market Size, 2016-2027
  6.4.5 Italy Cisplatin Market Size, 2016-2027
  6.4.6 Russia Cisplatin Market Size, 2016-2027
  6.4.7 Nordic Countries Cisplatin Market Size, 2016-2027
  6.4.8 Benelux Cisplatin Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cisplatin Revenue, 2016-2027
  6.5.2 China Cisplatin Market Size, 2016-2027
  6.5.3 Japan Cisplatin Market Size, 2016-2027
  6.5.4 South Korea Cisplatin Market Size, 2016-2027
  6.5.5 Southeast Asia Cisplatin Market Size, 2016-2027
  6.5.6 India Cisplatin Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cisplatin Revenue, 2016-2027
  6.6.2 Brazil Cisplatin Market Size, 2016-2027
  6.6.3 Argentina Cisplatin Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cisplatin Revenue, 2016-2027
  6.7.2 Turkey Cisplatin Market Size, 2016-2027
  6.7.3 Israel Cisplatin Market Size, 2016-2027
  6.7.4 Saudi Arabia Cisplatin Market Size, 2016-2027
  6.7.5 UAE Cisplatin Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Eli Lilly and Company
  7.1.1 Eli Lilly and Company Corporate Summary
  7.1.2 Eli Lilly and Company Business Overview
  7.1.3 Eli Lilly and Company Cisplatin Major Product Offerings
  7.1.4 Eli Lilly and Company Cisplatin Revenue in Global (2016-2021)
  7.1.5 Eli Lilly and Company Key News
7.2 Hospira
  7.2.1 Hospira Corporate Summary
  7.2.2 Hospira Business Overview
  7.2.3 Hospira Cisplatin Major Product Offerings
  7.2.4 Hospira Cisplatin Revenue in Global (2016-2021)
  7.2.5 Hospira Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Cisplatin Major Product Offerings
  7.3.4 Pfizer Cisplatin Revenue in Global (2016-2021)
  7.3.5 Pfizer Key News
7.4 Bedford Pharmaceuticals
  7.4.1 Bedford Pharmaceuticals Corporate Summary
  7.4.2 Bedford Pharmaceuticals Business Overview
  7.4.3 Bedford Pharmaceuticals Cisplatin Major Product Offerings
  7.4.4 Bedford Pharmaceuticals Cisplatin Revenue in Global (2016-2021)
  7.4.5 Bedford Pharmaceuticals Key News
7.5 Alvogen
  7.5.1 Alvogen Corporate Summary
  7.5.2 Alvogen Business Overview
  7.5.3 Alvogen Cisplatin Major Product Offerings
  7.5.4 Alvogen Cisplatin Revenue in Global (2016-2021)
  7.5.5 Alvogen Key News
7.6 Athenex Pharmaceutical
  7.6.1 Athenex Pharmaceutical Corporate Summary
  7.6.2 Athenex Pharmaceutical Business Overview
  7.6.3 Athenex Pharmaceutical Cisplatin Major Product Offerings
  7.6.4 Athenex Pharmaceutical Cisplatin Revenue in Global (2016-2021)
  7.6.5 Athenex Pharmaceutical Key News
7.7 Gland Pharma (Fosun Pharma)
  7.7.1 Gland Pharma (Fosun Pharma) Corporate Summary
  7.7.2 Gland Pharma (Fosun Pharma) Business Overview
  7.7.3 Gland Pharma (Fosun Pharma) Cisplatin Major Product Offerings
  7.4.4 Gland Pharma (Fosun Pharma) Cisplatin Revenue in Global (2016-2021)
  7.7.5 Gland Pharma (Fosun Pharma) Key News
7.8 West-Ward Pharmaceuticals
  7.8.1 West-Ward Pharmaceuticals Corporate Summary
  7.8.2 West-Ward Pharmaceuticals Business Overview
  7.8.3 West-Ward Pharmaceuticals Cisplatin Major Product Offerings
  7.8.4 West-Ward Pharmaceuticals Cisplatin Revenue in Global (2016-2021)
  7.8.5 West-Ward Pharmaceuticals Key News
7.9 WG Critical Care
  7.9.1 WG Critical Care Corporate Summary
  7.9.2 WG Critical Care Business Overview
  7.9.3 WG Critical Care Cisplatin Major Product Offerings
  7.9.4 WG Critical Care Cisplatin Revenue in Global (2016-2021)
  7.9.5 WG Critical Care Key News
7.10 David Bull Laboratories
  7.10.1 David Bull Laboratories Corporate Summary
  7.10.2 David Bull Laboratories Business Overview
  7.10.3 David Bull Laboratories Cisplatin Major Product Offerings
  7.10.4 David Bull Laboratories Cisplatin Revenue in Global (2016-2021)
  7.10.5 David Bull Laboratories Key News
7.11 Omega Laboratories
  7.11.1 Omega Laboratories Corporate Summary
  7.11.2 Omega Laboratories Business Overview
  7.11.3 Omega Laboratories Cisplatin Major Product Offerings
  7.11.4 Omega Laboratories Cisplatin Revenue in Global (2016-2021)
  7.11.5 Omega Laboratories Key News
7.12 Fresenius Kabi
  7.12.1 Fresenius Kabi Corporate Summary
  7.12.2 Fresenius Kabi Business Overview
  7.12.3 Fresenius Kabi Cisplatin Major Product Offerings
  7.12.4 Fresenius Kabi Cisplatin Revenue in Global (2016-2021)
  7.12.5 Fresenius Kabi Key News
7.13 TEVA
  7.13.1 TEVA Corporate Summary
  7.13.2 TEVA Business Overview
  7.13.3 TEVA Cisplatin Major Product Offerings
  7.13.4 TEVA Cisplatin Revenue in Global (2016-2021)
  7.13.5 TEVA Key News
7.14 Mylan Pharmaceuticals
  7.14.1 Mylan Pharmaceuticals Corporate Summary
  7.14.2 Mylan Pharmaceuticals Business Overview
  7.14.3 Mylan Pharmaceuticals Cisplatin Major Product Offerings
  7.14.4 Mylan Pharmaceuticals Cisplatin Revenue in Global (2016-2021)
  7.14.5 Mylan Pharmaceuticals Key News
7.15 Yunnan Plant Pharmaceutical
  7.15.1 Yunnan Plant Pharmaceutical Corporate Summary
  7.15.2 Yunnan Plant Pharmaceutical Business Overview
  7.15.3 Yunnan Plant Pharmaceutical Cisplatin Major Product Offerings
  7.15.4 Yunnan Plant Pharmaceutical Cisplatin Revenue in Global (2016-2021)
  7.15.5 Yunnan Plant Pharmaceutical Key News
7.16 Yunnan Biological Valley Pharmaceutical
  7.16.1 Yunnan Biological Valley Pharmaceutical Corporate Summary
  7.16.2 Yunnan Biological Valley Pharmaceutical Business Overview
  7.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Major Product Offerings
  7.16.4 Yunnan Biological Valley Pharmaceutical Cisplatin Revenue in Global (2016-2021)
  7.16.5 Yunnan Biological Valley Pharmaceutical Key News
7.17 Dezhou de Pharmaceutical
  7.17.1 Dezhou de Pharmaceutical Corporate Summary
  7.17.2 Dezhou de Pharmaceutical Business Overview
  7.17.3 Dezhou de Pharmaceutical Cisplatin Major Product Offerings
  7.17.4 Dezhou de Pharmaceutical Cisplatin Revenue in Global (2016-2021)
  7.17.5 Dezhou de Pharmaceutical Key News
7.18 Jiangsu Haosen Pharmaceutical Group
  7.18.1 Jiangsu Haosen Pharmaceutical Group Corporate Summary
  7.18.2 Jiangsu Haosen Pharmaceutical Group Business Overview
  7.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Major Product Offerings
  7.18.4 Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue in Global (2016-2021)
  7.18.5 Jiangsu Haosen Pharmaceutical Group Key News
7.19 Qilu Pharmaceutical
  7.19.1 Qilu Pharmaceutical Corporate Summary
  7.19.2 Qilu Pharmaceutical Business Overview
  7.19.3 Qilu Pharmaceutical Cisplatin Major Product Offerings
  7.19.4 Qilu Pharmaceutical Cisplatin Revenue in Global (2016-2021)
  7.19.5 Qilu Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cisplatin Market Opportunities & Trends in Global Market
Table 2. Cisplatin Market Drivers in Global Market
Table 3. Cisplatin Market Restraints in Global Market
Table 4. Key Players of Cisplatin in Global Market
Table 5. Top Cisplatin Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cisplatin Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cisplatin Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cisplatin Product Type
Table 9. List of Global Tier 1 Cisplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cisplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cisplatin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cisplatin Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cisplatin Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cisplatin Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cisplatin Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cisplatin Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cisplatin Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cisplatin Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cisplatin Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cisplatin Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cisplatin Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cisplatin Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cisplatin Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cisplatin Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cisplatin Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cisplatin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cisplatin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cisplatin Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cisplatin Revenue, (US$, Mn), 2022-2027
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Cisplatin Product Offerings
Table 32. Eli Lilly and Company Cisplatin Revenue (US$, Mn), (2016-2021)
Table 33. Hospira Corporate Summary
Table 34. Hospira Cisplatin Product Offerings
Table 35. Hospira Cisplatin Revenue (US$, Mn), (2016-2021)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Cisplatin Product Offerings
Table 38. Pfizer Cisplatin Revenue (US$, Mn), (2016-2021)
Table 39. Bedford Pharmaceuticals Corporate Summary
Table 40. Bedford Pharmaceuticals Cisplatin Product Offerings
Table 41. Bedford Pharmaceuticals Cisplatin Revenue (US$, Mn), (2016-2021)
Table 42. Alvogen Corporate Summary
Table 43. Alvogen Cisplatin Product Offerings
Table 44. Alvogen Cisplatin Revenue (US$, Mn), (2016-2021)
Table 45. Athenex Pharmaceutical Corporate Summary
Table 46. Athenex Pharmaceutical Cisplatin Product Offerings
Table 47. Athenex Pharmaceutical Cisplatin Revenue (US$, Mn), (2016-2021)
Table 48. Gland Pharma (Fosun Pharma) Corporate Summary
Table 49. Gland Pharma (Fosun Pharma) Cisplatin Product Offerings
Table 50. Gland Pharma (Fosun Pharma) Cisplatin Revenue (US$, Mn), (2016-2021)
Table 51. West-Ward Pharmaceuticals Corporate Summary
Table 52. West-Ward Pharmaceuticals Cisplatin Product Offerings
Table 53. West-Ward Pharmaceuticals Cisplatin Revenue (US$, Mn), (2016-2021)
Table 54. WG Critical Care Corporate Summary
Table 55. WG Critical Care Cisplatin Product Offerings
Table 56. WG Critical Care Cisplatin Revenue (US$, Mn), (2016-2021)
Table 57. David Bull Laboratories Corporate Summary
Table 58. David Bull Laboratories Cisplatin Product Offerings
Table 59. David Bull Laboratories Cisplatin Revenue (US$, Mn), (2016-2021)
Table 60. Omega Laboratories Corporate Summary
Table 61. Omega Laboratories Cisplatin Product Offerings
Table 62. Omega Laboratories Cisplatin Revenue (US$, Mn), (2016-2021)
Table 63. Fresenius Kabi Corporate Summary
Table 64. Fresenius Kabi Cisplatin Product Offerings
Table 65. Fresenius Kabi Cisplatin Revenue (US$, Mn), (2016-2021)
Table 66. TEVA Corporate Summary
Table 67. TEVA Cisplatin Product Offerings
Table 68. TEVA Cisplatin Revenue (US$, Mn), (2016-2021)
Table 69. Mylan Pharmaceuticals Corporate Summary
Table 70. Mylan Pharmaceuticals Cisplatin Product Offerings
Table 71. Mylan Pharmaceuticals Cisplatin Revenue (US$, Mn), (2016-2021)
Table 72. Yunnan Plant Pharmaceutical Corporate Summary
Table 73. Yunnan Plant Pharmaceutical Cisplatin Product Offerings
Table 74. Yunnan Plant Pharmaceutical Cisplatin Revenue (US$, Mn), (2016-2021)
Table 75. Yunnan Biological Valley Pharmaceutical Corporate Summary
Table 76. Yunnan Biological Valley Pharmaceutical Cisplatin Product Offerings
Table 77. Yunnan Biological Valley Pharmaceutical Cisplatin Revenue (US$, Mn), (2016-2021)
Table 78. Dezhou de Pharmaceutical Corporate Summary
Table 79. Dezhou de Pharmaceutical Cisplatin Product Offerings
Table 80. Dezhou de Pharmaceutical Cisplatin Revenue (US$, Mn), (2016-2021)
Table 81. Jiangsu Haosen Pharmaceutical Group Corporate Summary
Table 82. Jiangsu Haosen Pharmaceutical Group Cisplatin Product Offerings
Table 83. Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue (US$, Mn), (2016-2021)
Table 84. Qilu Pharmaceutical Corporate Summary
Table 85. Qilu Pharmaceutical Cisplatin Product Offerings
Table 86. Qilu Pharmaceutical Cisplatin Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Cisplatin Segment by Type
Figure 2. Cisplatin Segment by Application
Figure 3. Global Cisplatin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cisplatin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cisplatin Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cisplatin Revenue in 2020
Figure 8. By Type - Global Cisplatin Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cisplatin Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cisplatin Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cisplatin Revenue Market Share, 2016-2027
Figure 12. US Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cisplatin Revenue Market Share, 2016-2027
Figure 16. Germany Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 17. France Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cisplatin Revenue Market Share, 2016-2027
Figure 24. China Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 28. India Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cisplatin Revenue Market Share, 2016-2027
Figure 30. Brazil Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cisplatin Revenue Market Share, 2016-2027
Figure 33. Turkey Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cisplatin Revenue, (US$, Mn), 2016-2027
Figure 37. Eli Lilly and Company Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Hospira Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Pfizer Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bedford Pharmaceuticals Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Alvogen Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Athenex Pharmaceutical Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Gland Pharma (Fosun Pharma) Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. West-Ward Pharmaceuticals Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. WG Critical Care Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. David Bull Laboratories Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Omega Laboratories Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Fresenius Kabi Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. TEVA Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Mylan Pharmaceuticals Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Yunnan Plant Pharmaceutical Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Yunnan Biological Valley Pharmaceutical Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Dezhou de Pharmaceutical Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)